Zymeworks (ZYME) Current Assets (2021 - 2026)

Zymeworks has reported Current Assets for 6 years, with the latest figure at $385.7 million in Q1 2026.

• Quarterly Current Assets rose 25.85% year-over-year to $385.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $385.7 million (up 25.85% YoY) and the FY2025 annual result came in at $248.8 million, down 17.2% from the prior year.
• Current Assets rose to $385.7 million in Q1 2026 per ZYME's latest filing, from $248.8 million in the prior quarter.
• Over five years, Current Assets peaked at $544.7 million in Q4 2022 and troughed at $190.7 million in Q3 2022.
• A 5-year average of $354.7 million and a median of $374.6 million in 2023 frame the typical range for Current Assets.
• The sharpest annual moves came in 2023 and 2024: Current Assets surged 96.5% in 2023, then retreated 27.24% in 2024.
• Over 5 years, Current Assets stood at $544.7 million in 2022, then fell by 24.19% to $412.9 million in 2023, then slipped by 27.24% to $300.5 million in 2024, then slipped by 17.2% to $248.8 million in 2025, then surged by 55.04% to $385.7 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $385.7 million, $248.8 million, and $291.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.